Trials / Sponsors / Grupo Cooperativo de Hemopatías Malignas
Grupo Cooperativo de Hemopatías Malignas
Academic / Other · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Myeloid Mutations Register in R/R CML Chronic Myeloid Leukaemia Recurrent, Chronic Myeloid Leukemia, in Relapse | N/A | 2021-03-01 |
| Completed | Treatment of SARS Caused by COVID-19 With Ruxolitinib COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 | Phase 1 / Phase 2 | 2020-09-01 |
| Withdrawn | Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma Multiple Myeloma | Phase 3 | 2020-03-01 |
| Withdrawn | Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myelodysplastic Syndromes, Acute Myeloid Leukemia | — | 2020-01-01 |
| Completed | Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia B-Cell Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis) | Phase 2 | 2018-12-01 |